115 related articles for article (PubMed ID: 23912312)
21. [Impact of obesity on PSA in prostate cancer screening].
Larré S; Azzouzi AR; Cancel-Tassin G; Cormier L; Villette JM; Hoffmann P; Drelon I; Baschet F; Mangin P; Cussenot O
Prog Urol; 2007 Jun; 17(4):815-8. PubMed ID: 17633992
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
[TBL] [Abstract][Full Text] [Related]
23. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
24. Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006.
Ando R; Nagaya T; Hashimoto Y; Suzuki S; Itoh Y; Umemoto Y; Ikeda N; Tozawa K; Kohri K; Tokudome S
Urology; 2008 Sep; 72(3):561-5. PubMed ID: 18514773
[TBL] [Abstract][Full Text] [Related]
25. Obesity and prostate cancer detection: insights from three national surveys.
Parekh N; Lin Y; Dipaola RS; Marcella S; Lu-Yao G
Am J Med; 2010 Sep; 123(9):829-35. PubMed ID: 20800152
[TBL] [Abstract][Full Text] [Related]
26. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.
Li F; Shen Z; Lu Y; Yun J; Fan Y
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1731-4. PubMed ID: 22850805
[TBL] [Abstract][Full Text] [Related]
27. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
Chung BH; Hong SJ; Cho JS; Seong DH
BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
[TBL] [Abstract][Full Text] [Related]
28. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
29. Which obesity index best correlates with prostate volume, prostate-specific antigen, and lower urinary tract symptoms?
Yang HJ; Doo SW; Yang WJ; Song YS
Urology; 2012 Jul; 80(1):187-90. PubMed ID: 22626573
[TBL] [Abstract][Full Text] [Related]
30. Effect of body mass index on serum prostate-specific antigen levels among patients presenting with lower urinary tract symptoms.
Chiu PK; Wong AY; Hou SM; Yip SK; Ng CF
Asian Pac J Cancer Prev; 2011; 12(8):1937-40. PubMed ID: 22292628
[TBL] [Abstract][Full Text] [Related]
31. [Body mass index correlates with the level of serum prostate-specific antigen in men in Fangcheng area of Guangxi].
Wu YM; Gao Y; Tan AH; Qin X; Mo ZN
Zhonghua Nan Ke Xue; 2014 Jan; 20(1):19-22. PubMed ID: 24527532
[TBL] [Abstract][Full Text] [Related]
32. Body mass index and serum lipid profile influence serum prostate-specific antigen in Chinese men younger than 50 years of age.
Liu M; Wang JY; Zhu L; Wan G
Asian J Androl; 2011 Jul; 13(4):640-3. PubMed ID: 21170076
[TBL] [Abstract][Full Text] [Related]
33. The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS.
Adegun PT; Adebayo PB; Atiba SA
Asian J Urol; 2015 Jul; 2(3):158-162. PubMed ID: 29264136
[TBL] [Abstract][Full Text] [Related]
34. Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men.
Han JH; Lee YT; Kwak KW; Ahn SH; Chang IH; Myung SC; Oh SY; Lee YS; Kim W; Jin YW; Choi TI; Sung SH
Asian J Androl; 2010 May; 12(3):400-4. PubMed ID: 20305674
[TBL] [Abstract][Full Text] [Related]
35. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
36. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
[TBL] [Abstract][Full Text] [Related]
37. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.
Yang WJ; Lee DH; Chung BH; Cho JS; Choi YD; Kim SJ; Cho IR; Kim HS; Kim CI; Hong SJ;
Urology; 2006 Feb; 67(2):333-6. PubMed ID: 16461083
[TBL] [Abstract][Full Text] [Related]
38. The effect of demographic and clinical factors on the relationship between BMI and PSA levels.
Wright JL; Lin DW; Stanford JL
Prostate; 2011 Nov; 71(15):1631-7. PubMed ID: 21432865
[TBL] [Abstract][Full Text] [Related]
39. Body mass index and prostate specific antigen levels in Jamaican men.
Tulloch-Reid MK; Aiken WD; Morrison BF; Tulloch T; Mayhew R; Wan RL; Bennett FI; Coard KC; Jackson MD
West Indian Med J; 2011 Jun; 60(3):316-21. PubMed ID: 22224345
[TBL] [Abstract][Full Text] [Related]
40. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
